Marc C Chamberlain, Michael J Glantz. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultAgedAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/adverse effectsCyclophosphamide/administration & dosageCyclophosphamide/adverse effectsCytarabine/administration & dosageCytarabine/adverse effectsDexamethasone/administration & dosageDexamethasone/adverse effectsDoxorubicin/administration & dosageDoxorubicin/adverse effectsEncephalitis/chemically inducedFemaleHumansInjections, SpinalLeukemic Infiltration/mortalityLeukemic Infiltration/pathologyLeukemic Infiltration/prevention & controlLiposomesMaleMeninges/pathologyMeningitis/mortalityMeningitis/pathologyMeningitis/prevention & controlMethotrexate/administration & dosageMethotrexate/adverse effectsMiddle AgedPapilledema/chemically inducedPolyradiculopathy/chemically inducedPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/mortalityPrecursor Cell Lymphoblastic Leukemia-Lymphoma/pathologySeizures/chemically induced
Substances: See more » LiposomesCytarabineDexamethasoneDoxorubicinCyclophosphamideMethotrexate
Year: 2007 PMID: 17712051 DOI: 10.1182/blood-2007-02-073536
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113